RGS5 and neoplasm: To test the effects of tubulin-binding drugs on highly proliferating pericytes, we used an in vitro model which overexpresses the Regulator of G protein signaling 5 (RGS5) that is highly upregulated in angiogenic tumor pericytes (Hamzah et al, 2008).